Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailing Lu

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Cell Communication and Signaling : CCS|August 2, 2018
TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathwayYing Xing, Yuechao Liu, Tianbo Liu, et al.
Frontiers in Cell and Developmental Biology|July 29, 2020
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for ImmunotherapyYang Song, Shi Yan, Weina Fan, et al.
JAMA Oncology|January 24, 2017
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical TrialLupe G Salazar, Hailing Lu, Jessica L Reichow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2010
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockadeHailing Lu, Wolfgang M Wagner, Ekram Gad, et al.
International Journal of Biological Sciences|September 14, 2023
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinomaJinfang Cui, Yuchao He, Fuyi Zhu, et al.
Vaccines|February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast CancerWilliam R Gwin, Lupe G Salazar, James Y Dai, et al.
Journal of Translational Medicine|June 3, 2014
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancerJianning Mao, Jon Ladd, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCCHailing Lu, Gregory N Dietsch, Maura-Ann H Matthews, et al.
Blood|January 25, 2003
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeysJan Storek, Thurman Gillespy, Hailing Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaShailender Bhatia, Natalie J Miller, Hailing Lu, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Cell Communication and Signaling : CCS|August 2, 2018
TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathwayYing Xing, Yuechao Liu, Tianbo Liu, et al.
Frontiers in Cell and Developmental Biology|July 29, 2020
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for ImmunotherapyYang Song, Shi Yan, Weina Fan, et al.
JAMA Oncology|January 24, 2017
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical TrialLupe G Salazar, Hailing Lu, Jessica L Reichow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2010
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockadeHailing Lu, Wolfgang M Wagner, Ekram Gad, et al.
International Journal of Biological Sciences|September 14, 2023
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinomaJinfang Cui, Yuchao He, Fuyi Zhu, et al.
Vaccines|February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast CancerWilliam R Gwin, Lupe G Salazar, James Y Dai, et al.
Journal of Translational Medicine|June 3, 2014
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancerJianning Mao, Jon Ladd, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCCHailing Lu, Gregory N Dietsch, Maura-Ann H Matthews, et al.
Blood|January 25, 2003
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeysJan Storek, Thurman Gillespy, Hailing Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaShailender Bhatia, Natalie J Miller, Hailing Lu, et al.
Pageof 9